Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,571 across all filing types
Latest filing 2023-04-21 Proxy Solicitation & In…
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
FORM DFAN14A
Proxy Solicitation & Information Statement
2023-04-21 English
Remuneration Information 2023
Remuneration Information Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or related materials filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It contains detailed information about the company's board of directors, solicitation of proxies for the Annual Meeting of Stockholders, voting instructions, and background on board nominees. The document references the 2023 Annual Meeting and proxy solicitation materials, including a white proxy card and opposition to nominees from Carl Icahn. It does not contain financial statements or earnings data, nor is it an announcement of financial results or a report on executive compensation alone. The document is clearly a proxy solicitation and related materials, which corresponds to the Remuneration Information (DEF 14A) category, as Schedule 14A filings typically include executive compensation and director election information. The document is 15,000 characters long, indicating it is a full filing, not a brief announcement or notice. Therefore, the appropriate classification is DEF 14A with high confidence.
2023-04-20 English
ARS
Annual Report
2023-04-20 English
DEFC14A
Proxy Solicitation & Information Statement
2023-04-20 English
Regulatory Filings 2023
Regulatory Filings Classification · 60% confidence The provided document text appears to be heavily encoded or corrupted, containing no readable or meaningful content related to financial reporting, regulatory announcements, or corporate filings. There are no identifiable keywords, regulatory references, fiscal period dates, or document titles that would allow classification into any specific filing category. Given the lack of discernible information and the fallback rule for documents that do not fit any category, the appropriate classification is Regulatory Filings (RNS). The confidence is moderate due to the inability to extract meaningful content.
2023-04-17 English
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes solicitation materials for the 2023 Annual Meeting of Stockholders of Illumina, Inc. The text references the proxy statement, director nominations, board composition, and shareholder voting matters. It also explicitly states it is a "Soliciting Material under Rule 14a-12" and discusses proxy solicitation and voting. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document is lengthy (15,000 characters) and contains detailed information rather than just an announcement or a brief summary, confirming it is the proxy solicitation material itself, not just a notice or announcement. Therefore, the correct classification is PSI with high confidence.
2023-04-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.